Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,778,581 | 4,778,581 | 0 | $119.23M | $132.61M | 57.73% | +$13.38M |
| Cytokinetics, Incorporated(CYTK) | 458,295 | 458,295 | 0 | $25.19M | $29.12M | 12.68% | +$3.93M |
| Lyell Immunopharma, Inc.(LYEL) | 800,399 | 800,399 | 0 | $13.00M | $24.64M | 10.72% | +$11.64M |
| Maze Therapeutics, Inc.(MAZE) | 522,657 | 522,657 | 0 | $13.55M | $21.65M | 9.43% | +$8.10M |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | $5.22M | $8.46M | 3.68% | +$3.24M |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | $6.42M | $7.17M | 3.12% | +$747.2K |
| Alector, Inc. | 0 | 3,887,200 | +3,887,200 | $0 | $6.06M | 2.64% | +$6.06M |